Show simple item record

The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for AnxietyShow simple item record

dc.creatorChing N. R.
dc.creatorAlzghari A. K.
dc.creatorAlzghari S. K.
dc.date.accessioned2019-07-12T16:02:36Z
dc.date.available2019-07-12T16:02:36Z
dc.date.issued2018-08-13
dc.identifier.urihttps://doi.org/10.7759/cureus.3133
dc.identifier.urihttps://repository.tcu.edu/handle/116099117/26467
dc.identifier.urihttps://www.cureus.com/articles/13678-the-relationship-of-ugt2b15-pharmacogenetics-and-lorazepam-for-anxiety
dc.description.abstractAnxiety affects over 260 million people worldwide. Benzodiazepines are a class of agents used in combination with other therapies for the management of anxiety. Lorazepam is a commonly prescribed benzodiazepine metabolized by uridine 5'-diphosphate-glucuronosyltransferases. Herein, we discuss recent findings regarding the pharmacogenetics of uridine 5'-diphosphate-glucuronosyltransferase 2B15 (UGT2B15), lorazepam, and its role in the treatment of anxiety.
dc.language.isoenen_US
dc.publisherCureus
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/
dc.sourceCureus
dc.subjectlorazepam
dc.subjectsingle nucleotide polymorphisms
dc.subjectanxiety
dc.subjectpharmacogenetics
dc.subjectugt2b15
dc.titleThe Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety
dc.typeArticle
dc.rights.holderChing N R et al.
dc.rights.licenseCC BY 3.0
local.collegeCollege of Science and Engineering
local.departmentChemistry and Biochemistry
local.personsChing (CHEM)


Files in this item

Thumbnail
Name:
content.pdf
Size:
71.49Kb
Format:
PDF

View/Open

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/3.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/3.0/
© TCU Library 2015 | Contact Special Collections |